Ensuring Patient Access to Critical Breakthrough Products Act of 2024

The Frame

What this does

This bill changes how quickly Medicare beneficiaries gain access to cutting-edge medical technology by mandating immediate payment pathways for FDA-designated s, potentially reducing the time patients wait for new treatments.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

Medicare beneficiaries

They gain access to breakthrough medical devices through a new, expedited coverage and payment pathway.

Medical device manufacturers

They receive a guaranteed 4-year transitional payment period for devices that meet the breakthrough designation.

Healthcare providers

They are subject to new coding and payment updates for breakthrough devices used in inpatient and outpatient settings.

What changed

Last recorded activity December 24, 2024.

What's next

Introduced.

Summary

This bill creates a four-year '' period for new medical devices designated as 'breakthrough' by the FDA, ensuring they are automatically covered and paid for by Medicare. It requires the government to quickly assign payment codes to these devices and establishes a process for long-term coverage decisions after the initial four-year period.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Why It Matters

This bill changes how quickly Medicare beneficiaries gain access to cutting-edge medical technology by mandating immediate payment pathways for FDA-designated s, potentially reducing the time patients wait for new treatments.

Frequently Asked Questions

What is a 'breakthrough device' under this bill?

It is a medical device that has received review priority from the FDA and has been approved or cleared for use on or after March 15, 2021.

Does this bill guarantee coverage forever?

No, it provides a 4-year period. After that, the Secretary of HHS must establish a process to determine long-term coverage based on collected data and evidence.

Can Medicare stop paying for a device if it is found to be harmful?

Yes, the bill explicitly states that the Secretary retains the authority to suspend or terminate coverage if clinical evidence shows the device provides no benefit or causes serious harm.

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift100% confidence

Shift to Automatic Transitional Coverage

The bill moves away from a case-by-case coverage determination for breakthrough devices toward an automatic, time-limited transitional coverage model.

Social Security Act

Connected Entities

personBilirakis“Co-sponsor of the bill”Map →

otherFederal Food, Drug, and Cosmetic Act“The law defining a 'medical device'”Map →

personCardenas“Co-sponsor of the bill”Map →

personMoore of Utah“Co-sponsor of the bill”Map →

personSewell“Co-sponsor of the bill”Map →

otherSocial Security Act“The law being amended”Map →

personEshoo“Co-sponsor of the bill”Map →

personSecretary“The Secretary of Health and Human Services”Map →

personGuthrie“Co-sponsor of the bill”Map →

personDelBene“Co-sponsor of the bill”Map →

organizationU.S. Government Publishing Office“Source of the bill's documentation”Map →

personWenstrup“Lead sponsor of the bill”Map →

Analysis Score

0–100

Significance85
How much this matters to a regular citizen
Controversy40
Intensity of disagreement among stakeholders
Entertainment5
Compellingness for a non-policy-wonk reader
Buzz30
Current news / social attention level